Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leyre Oteiza Zubiri, M.D., Ph.D.

Concepts (157)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms162022216830.570 Why?
Myocarditis520227710.490 Why?
Melanoma10202355100.480 Why?
Immunotherapy4202144450.450 Why?
Cross Infection1202114160.410 Why?
Exanthema220245010.330 Why?
Thyroiditis12021850.200 Why?
Colitis2201911700.190 Why?
Hypokalemia120211530.190 Why?
Extracellular Matrix Proteins220158490.180 Why?
Lymphatic Diseases120223240.180 Why?
Censuses120212000.180 Why?
Enterocolitis120201020.170 Why?
Pericardial Effusion120212470.170 Why?
Hyponatremia120212980.160 Why?
Lymphocyte Count120207930.160 Why?
Ablation Techniques120212490.150 Why?
Carcinoma, Non-Small-Cell Lung3202252210.150 Why?
Anemia, Hemolytic, Autoimmune120191420.150 Why?
Budgets120192290.150 Why?
Renin-Angiotensin System120227590.150 Why?
Retrospective Studies222023774490.150 Why?
Lung Neoplasms42022131020.140 Why?
Drug Eruptions120192970.140 Why?
Intramolecular Oxidoreductases120151090.130 Why?
Heart Conduction System1202110470.130 Why?
Inpatients3202125180.130 Why?
Neoplasms, Second Primary1202210610.120 Why?
Chemistry, Clinical12015640.120 Why?
Adrenal Cortex Hormones2202018550.120 Why?
Celiac Disease120227850.120 Why?
Proto-Oncogene Proteins B-raf2201420430.120 Why?
Skin Neoplasms3202356860.120 Why?
Combined Modality Therapy3202286420.120 Why?
Humans4520247443430.120 Why?
Action Potentials1202118060.110 Why?
Patient Admission1202113800.110 Why?
Middle Aged2320222133830.110 Why?
S100 Proteins120132590.110 Why?
Brachytherapy1202112480.110 Why?
Hemoglobins1201915340.110 Why?
Neoplasm Proteins2201537030.100 Why?
Male2720223501180.100 Why?
Aged2020221632800.100 Why?
Drug Costs1201911050.100 Why?
Exosomes120154170.100 Why?
Embolization, Therapeutic1202113920.100 Why?
Nervous System Diseases1202116220.090 Why?
Pneumonia1202221330.090 Why?
Heart Rate1202140910.090 Why?
Plaque, Atherosclerotic1202015190.080 Why?
Neutrophils1202037190.080 Why?
Female2220223801940.080 Why?
Electrocardiography1202164420.080 Why?
Renal Insufficiency, Chronic1202122080.070 Why?
Acute Kidney Injury1201919720.070 Why?
Cohort Studies72023405610.070 Why?
Incidence52023209470.070 Why?
DNA Mutational Analysis1201441860.070 Why?
Risk Factors92022722900.070 Why?
Polymerase Chain Reaction1201461710.060 Why?
Liver1202074740.060 Why?
Atherosclerosis1202034450.060 Why?
Radioimmunotherapy12024910.060 Why?
Practice Guidelines as Topic1202172790.060 Why?
Pandemics2202183880.060 Why?
Aged, 80 and over72022577760.060 Why?
DNA2201573010.060 Why?
Neoplasm Staging42019110310.060 Why?
Genome-Wide Association Study12022122610.060 Why?
Consensus2202429590.060 Why?
L-Lactate Dehydrogenase220154240.060 Why?
Treatment Outcome52021631140.050 Why?
Glomerular Filtration Rate2202121700.050 Why?
Interleukin-7120221420.050 Why?
Coronavirus Infections1202031330.050 Why?
Pneumonia, Viral1202032400.050 Why?
Time Factors52021400750.050 Why?
Antibodies, Monoclonal1201992740.050 Why?
Hypertension1202284800.050 Why?
Drug Administration Schedule2202049330.050 Why?
Predictive Value of Tests32022150760.050 Why?
Electrolytes120212820.050 Why?
Antineoplastic Agents22020136950.040 Why?
Takotsubo Cardiomyopathy120211250.040 Why?
Risk Assessment42021233380.040 Why?
Myocardial Infarction12020117270.040 Why?
Azithromycin120201960.040 Why?
Biopsy2202167560.040 Why?
Germ Cells120226310.040 Why?
Cardiac Imaging Techniques120212690.040 Why?
Massachusetts2202186630.040 Why?
Prognosis42020290630.040 Why?
Troponin T120227540.040 Why?
Tomography, X-Ray Computed12020201290.040 Why?
Disease-Free Survival2202068950.040 Why?
Hospitalization32021102620.040 Why?
Myocardial Revascularization120208410.030 Why?
Hydroxychloroquine120204120.030 Why?
Sodium1202116230.030 Why?
Neoplasm Metastasis2201948510.030 Why?
Angiotensin Receptor Antagonists120229240.030 Why?
Markov Chains120199690.030 Why?
Databases, Factual2202177290.030 Why?
Angiotensin-Converting Enzyme Inhibitors1202215180.030 Why?
Registries2202180890.030 Why?
Ligands1202232820.030 Why?
Models, Economic120197130.030 Why?
Proton Pump Inhibitors120195260.030 Why?
Creatinine1201919190.030 Why?
Oximes120143110.030 Why?
Disease Progression22020132840.030 Why?
ROC Curve1202035270.030 Why?
Quality-Adjusted Life Years1201916830.030 Why?
Immunotherapy, Adoptive1202112700.030 Why?
Antihypertensive Agents1202220460.030 Why?
Adult620222140550.030 Why?
Mutation12014297860.020 Why?
Academic Medical Centers1202027590.020 Why?
Patient Care Team1202125310.020 Why?
Ventricular Function, Left1202236700.020 Why?
Cause of Death1202035840.020 Why?
Glucocorticoids1201921070.020 Why?
Stroke Volume1202250070.020 Why?
Decision Support Techniques1201919560.020 Why?
Imidazoles1201412060.020 Why?
Skin1202243640.020 Why?
Neoplastic Cells, Circulating120159340.020 Why?
Immunosuppressive Agents1202141490.020 Why?
Dose-Response Relationship, Drug12020109430.020 Why?
Molecular Targeted Therapy1201927270.020 Why?
Antiviral Agents1202029870.020 Why?
Intensive Care Units1202136790.020 Why?
MAP Kinase Signaling System1201515260.020 Why?
Boston1202093130.020 Why?
Prospective Studies22022532880.020 Why?
Indoles1201418390.020 Why?
Cost-Benefit Analysis1201953910.020 Why?
Kidney1202171860.020 Why?
Comorbidity12020103880.020 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202032550.020 Why?
Cognition1202267700.020 Why?
Sulfonamides1201419380.020 Why?
Survival Rate12019127880.020 Why?
Kaplan-Meier Estimate1201465380.010 Why?
Case-Control Studies12020217460.010 Why?
United States22021698720.010 Why?
Proteomics1201536380.010 Why?
Severity of Illness Index12019155400.010 Why?
Cytokines1201573220.010 Why?
Cell Line, Tumor12015166890.010 Why?
Quality of Life12019128040.010 Why?
Protein Kinase Inhibitors1201355350.010 Why?
Young Adult12022564300.010 Why?
Cardiovascular Diseases12020151650.010 Why?
Follow-Up Studies12014390500.010 Why?
Adolescent12019857810.010 Why?
Zubiri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Co-Authors (133)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.